CAR-T Cell Therapies for Hematological Malignancies
12 Questions
4 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What was a crucial stepstone in the progress of adoptive cell therapies?

  • The discovery of Graft-versus-Host Disease
  • The authorization of Kymriah by the FDA in 2017 (correct)
  • The approval of five more CAR-T therapies
  • The development of non-viral transfection technologies

What is a major advantage of Natural Killer cells over CAR-T cell therapies?

  • They avoid severe side-effects such as GvHD and CRS (correct)
  • They are associated with more severe side-effects
  • They are more effective in treating solid tumors
  • They are easier to genetically modify

What is a limitation of using viral vectors for NK cell modification?

  • They require a lengthy and expensive product development process (correct)
  • They are not effective in treating hematological malignancies
  • They can only be used for T-cells
  • They are too expensive to develop

What is the goal of non-viral transfection technologies?

<p>To address the shortcomings of viral vectors (B)</p> Signup and view all the answers

Why are non-viral transfection technologies being developed?

<p>To overcome the limitations and risks of viral vectors (D)</p> Signup and view all the answers

What is the focus of the review mentioned in the text?

<p>The potential of NK cells in cancer immunotherapies (B)</p> Signup and view all the answers

What is the primary function of natural killer cells in immunosurveillance?

<p>To recognize and eliminate virally infected cells and tumor cells (B)</p> Signup and view all the answers

What is the primary difference between the activation mechanisms of CD8+ T cells and natural killer cells?

<p>CD8+ T cells require antigen presentation, whereas NK cells do not (A)</p> Signup and view all the answers

What is the role of inhibitory receptors such as KIR and NKG2A on natural killer cells?

<p>To inhibit NK cell activation and prevent autoimmune responses (A)</p> Signup and view all the answers

What is the purpose of the balance between activating and inhibitory signals in natural killer cells?

<p>To determine the activation or inhibition of NK cells (A)</p> Signup and view all the answers

What is the effect of interferon γ (IFN-γ) produced by activated natural killer cells?

<p>It increases cytokine production and activates macrophages (D)</p> Signup and view all the answers

What is the consequence of a mismatch in HLA typing during allogenic therapy?

<p>Graft-versus-Host Disease (GvHD) occurs (C)</p> Signup and view all the answers

Study Notes

Adoptive Cell Therapies

  • Kymriah (tisagenlecleucel) was authorized by the FDA in 2017, marking a crucial step forward in treating blood cancers.
  • Five more CAR-T therapies have been approved for the treatment of hematological malignancies since then.

Limitations of CAR-T Cell Therapies

  • CAR-T cell therapies are associated with severe side-effects such as Graft-versus-Host Disease (GvHD), cytokine release syndrome (CRS), and neurotoxicity.

Natural Killer (NK) Cells

  • NK cells are innate, cytotoxic lymphocytes that contribute to immunosurveillance by identifying and killing virally infected cells and tumor cells.
  • NK cells can be genetically modified to improve their therapeutic efficacy in various ways.
  • Viral transduction of NK cells remains inefficient and induces cytotoxic effects.

Non-Viral Transfection Technologies

  • Non-viral transfection technologies are being developed to address the shortcomings of viral vectors.
  • These technologies aim to engineer NK cells for cancer immunotherapies.

Mechanism of NK Cells

  • NK cells do not rely on antigen-specific receptors for their activation.
  • Their activation depends on the integration of signals derived from inhibitory and activating receptors expressed on their surface.
  • Inhibitory receptors such as Killing Inhibitory Receptor (KIR) and NKG2A can interact with MHC-associated molecules and inhibit NK cell activation.
  • Activating receptors such as NKG2D, Natural Cytotoxicity Receptors (NCRs), and DNAM-1 can result in NK cell activation upon interaction with tumor ligands.

Cytotoxicity and Immune Response

  • NK cells can mediate cytotoxicity immediately upon interaction with the target cell.
  • Upon activation, they release cytolytic granules and cytotoxic cytokines such as interferon γ (IFN-γ) and granulocyte-macrophage colony-stimulating factor (GM-CSF).
  • These chemokines and cytokines influence an array of immune cells, including B and T cells, macrophages, neutrophils, and dendritic cells.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

Learn about the developments in CAR-T cell therapies, approved treatments, and associated side-effects in the treatment of blood cancers.

More Like This

CAR T-cell Therapy Process
10 questions

CAR T-cell Therapy Process

WellManneredCarbon avatar
WellManneredCarbon
CAR T-Cell Therapy in B-ALL Patients
37 questions
CAR T-Cell Therapy in Childhood Cancer
5 questions
CAR T-cell Therapy in Childhood Leukemia
5 questions
Use Quizgecko on...
Browser
Browser